Lipoprotein(a) and the risk of cardiovascular disease in the European population: results from the BiomarCaRE consortium

AIMS: As promising compounds to lower Lipoprotein(a) (Lp(a)) are emerging, the need for a precise characterization and comparability of the Lp(a)-associated cardiovascular risk is increasing. Therefore, we aimed to evaluate the distribution of Lp(a) concentrations across the European population, to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Eur Heart J
Huvudupphovsmän: Waldeyer, Christoph, Makarova, Nataliya, Zeller, Tanja, Schnabel, Renate B., Brunner, Fabian J., Jørgensen, Torben, Linneberg, Allan, Niiranen, Teemu, Salomaa, Veikko, Jousilahti, Pekka, Yarnell, John, Ferrario, Marco M., Veronesi, Giovanni, Brambilla, Paolo, Signorini, Stefano G., Iacoviello, Licia, Costanzo, Simona, Giampaoli, Simona, Palmieri, Luigi, Meisinger, Christa, Thorand, Barbara, Kee, Frank, Koenig, Wolfgang, Ojeda, Francisco, Kontto, Jukka, Landmesser, Ulf, Kuulasmaa, Kari, Blankenberg, Stefan
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2017
Ämnen:
Meta-Analysis
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5837491/
https://ncbi.nlm.nih.gov/pubmed/28449027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehx166
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk